You can buy or sell CORV and other stocks, options, ETFs, and crypto commission-free!
Correvio Pharma Corp. operates as a pharmaceutical company, which engages in the provision of development and commercialization of medical products. It operates through the Europe and Rest of the World geographical segments. Read More The firm focuses on cardiovascular therapies that will improve the quality of life and health of patients suffering from heart disease. It offers the Brinavess and Aggrastat products to customers such as physicians, patients, and healthcare systems. The company was founded in 1986 and is headquartered in Vancouver, Canada.
Vancouver, British Columbia
52 Week High
52 Week Low
Correvio Pharma to explore sale after FDA panel setback, shares plunge(Reuters) - Correvio Pharma Corp on Wednesday said it would explore options including putting itself up for sale, a day after a panel of experts advising the U.
Correvio Pharma to consider a sale after FDA adcomm voteShares of Correvio Pharma CORV, +7.69% tumbled 54% in premarket trading after the specialty drugmaker said it was considering a sale of the company or its asset
Expected Mar 11, Pre-Market